,i #aafth ,,congress #b;d ,session ,h4 ,r4 #eggd ,,in ,,the ,,house ,,of ,,representatives ,february #f1 #bjbj,mr4 ,murphy of ,north ,carolina 7for himself and ,mr4 ,peterson7 introduced the following bill2 which was referred to the ,committee on ,veterans' ,affairs ,a ,,bill ,to direct the ,secretary of ,veterans ,affairs to conduct a review on opioid overdose deaths among veterans1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,veterans ,heroin ,overdose ,prevention ,examination ,act or the ,veterans ,,hope ,act4 #b4 ,findings2 sense of ,congress 7a7 ,findings ,congress finds the following3 7#a7 ,new research shows that a dramatic rise in opioid overdose deaths among veterans in recent years has happened increasingly among veterans dying from heroin and synthetic opioids4 7#b7 ,furthermore1 patients of the ,veterans ,health ,administration of the ,department of ,veterans ,affairs are seven more times likely to suffer from an opioid use disorder than commercially insured patients4 7#c7 ,using records of the ,veterans ,health ,administration linked to ,national ,death ,index data1 the veterans' rate of overdose deaths from all opioids increased by #fe percent from #bjaj to #bjaf1 a rate change that includes adjustments for demographic changes in the veteran population over time4 7#d7 ,furthermore1 among all opioid overdose decedents1 prescription opioid receipt within three months before death declined from #ed percent in #bjaj to #bf percent in #bjaf1 yet veteran overdoses resulting in death from heroin1 synthetic opioids such as fentanyl1 and nonprescription opioids still occurred4 7#e7 ,in fact1 between #bjaj and #bjaf1 the veteran death rate from heroin or from taking multiple opioids almost quintupled and the death rate from synthetic opioids such as fentanyl increased by more than five-fold4 7#f7 ,trends would suggest that1 while the aggregate rise in opioid overdose deaths among veterans parallel those seen in the general population1 the increase occurred mainly because of a rise in deaths from nonprescribed sources such as heroin1 fentanyl1 other powerful synthetic opioids1 or multiple opioids in concurrent use4 7b7 ,sense of ,congress ,it is the sense of ,congress that further veterans overdose prevention efforts and research should extend beyond patients actively receiving opioid prescriptions4 #c4 ,review of deaths of veterans relating to opioid use 7a7 ,review ,not later than #ah months after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs shall complete a review of the deaths of all covered veterans who died from opioid overdoses during the five-year period preceding the date of the enactment for this ,act4 7b7 ,matters included ,the review under subsection 7a7 shall include the following3 7#a7 ,the total number of covered veterans who died from opioid overdoses during the five-year period preceding the date of the enactment of this ,act4 7#b7 ,a summary of such veterans that includes the age1 sex1 and race1 and ethnicity of each such veteran4 7#c7 ,a comprehensive list of the medications prescribed to1 and found in the bodies of1 such veterans at the time of death1 specifically listing any medications that carry a black box warning1 are off-label1 or are psychotropic4 7#d7 ,a summary of medical diagnoses by physicians of the ,department of ,veterans ,affairs that led to any prescribing of the medications referred to in paragraph 7#c74 7#e7 ,the number of instances in which such a veteran was concurrently on multiple medications prescribed by physicians of the ,department4 7#f7 ,a summary of-- 7,a7 the average period that elapsed between the last prescription opioid receipt and the date of the death of such a veteran2 and 7,b7 the cause of death for each such veteran4 7#g7 ,the percentage of such veterans with combat experience or trauma 7including military sexual trauma1 traumatic brain injury1 and post-traumatic stress74 7#h7 ,identification of medical facilities of the ,department with high prescription and drug abuse treatment rates for patients being treated at those facilities4 7#i7 ,a description of policies of the ,department governing the prescribing of medications referred to in paragraph 7#c74 7#aj7 ,a description of efforts by the ,secretary to electronically track1 collect1 and properly dispose of prescription opioids that are either unused1 past the prescription date1 or not in the possession of the properly prescribed patient4 7#aa7 ,a description of any patterns apparent to the ,secretary based on the review4 7#ab7 ,recommendations for further action that would improve the safety and well-being of veterans and reduce opioid overdose rates for veterans1 especially concerning research regarding such veterans who had not filed for a opioid prescription in the three months before death by overdose4 7c7 ,public availability ,not later than #de days after the completion of the review under subsection 7a71 the ,secretary shall-- 7#a7 submit to ,congress a report on the results of the review2 7#b7 make such report publicly available2 and 7#c7 provide to the ,committees on ,veterans' ,affairs of the ,house of ,representatives and the ,senate a briefing on such review4 7d7 ,definitions ,in this section3 7#a7 ,the term black box warning means a warning displayed within a box in the prescribing information for drugs that have special problems1 particularly ones that may lead to death or serious injury4 7#b7 ,the term covered veteran means any veteran who received hospital care or medical services furnished by the ,department of ,veterans ,affairs during the five-year period preceding the death of the veteran4